Nurx Launches Telehealth HIV Prevention Service Line
In a major step forward for HIV prevention, Nurx, a direct-to-consumer telemedicine platform, announced the launch of a new at-home lab testing kit for patients seeking PrEP, a medication that helps keep HIV negative people from becoming infected.
Nurx’s at-home test kits will be available in 19 states and Washington, D.C., at launch. The kit allows patients to discreetly complete all the testing required before initiating PrEP, including a fourth generation HIV test and kidney monitoring. While Nurx has offered PrEP treatment since 2016, according to the company, this is the first time any company has been able to offer a service that allows patients to consult with a provider as to whether PrEP is right for them, complete the necessary lab work, receive a prescription, fill the prescription, and get PrEP medication delivered straight to their door—all without needing to visit a physical health clinic.
Nurx raised $36 million in Series B funding to expand the reach and scope of its platform to those who traditionally lack access to affordable prescriptions and primary healthcare services.